Fund I’s success highlighted by DPI-producing acquisitions, top-decile portfolio performance, and the GPs’ hands-on role in helping portfolio companies build top-tier teams Swell VC, an early-stage venture capital firm that invests in market-defining opportunities, has closed Fund II with $11.5 million in commitments. The fund’s backers include a diverse mix of successful founders, family offices […]
Gene Turner Named President Global Chief Client Officer; David Campanelli Named President, Global Investment Horizon Media, the largest media agency in the U.S. and the largest independent globally, today announced the elevation of two senior executives to drive rapid integration of the agency’s core offerings and accelerated business outcomes for its clients. These leadership appointments
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Oct. 15, 2024 (GLOBE NEWSWIRE) — NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a growing home health care organization, is pleased to announce that it has executed a definitive agreement (the “Agreement”), dated October
Westford, USA, Oct. 15, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the Ethylene market will attain a value of USD 194.7 billion by 2031, with a CAGR of 6% over the forecast period (2024-2031). Rapidly surging demand for packaged products and growing advancements in packaging technology are projected to augment the demand for ethylene in
The following issues have been halted by CIRO: Company: Dore Copper Mining Corp. TSX Symbol: DCMC All Issues: Yes Reason: Pending News Halt Time (ET): 7:44 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair
Patent covers proprietary method using methylation of the CCNA1 gene to help detect esophageal precancer and cancer Lucid Diagnostics Inc.(Nasdaq: LUCD)(“Lucid” or the “Company”), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that it has received a Notice of Allowance from the United States Patent and Trademark
35 sites active and enrolling in pivotal Phase 3 study of Bria-IMT(TM) combination with immune check point inhibitor in metastatic breast cancer (MBC) Primary endpoint is overall survival (OS) with Bria-IMT(TM) regimen plus Check Point Inhibitor (CPI) vs treatment of physician’s choice Interim data analysis planned at 144 events (deaths) could provide full approval and
WESTON, Fla., Oct. 15, 2024 (GLOBE NEWSWIRE) — ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA, or “ZyVersa”), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of inflammatory and renal diseases, announces that Stephen C. Glover, Co-Founder, Chairman, Chief Executive Officer, and President, was interviewed on the Big Biz Show to address current trends in
JACKSONVILLE, Fla., Oct. 15, 2024 (GLOBE NEWSWIRE) — Landstar System, Inc. (NASDAQ:LSTR), announced today it will release its 2024 third quarter results after the market closes on Tuesday, October 29, 2024, and will then hold its quarterly conference call with analysts and investors at 4:30 p.m. ET that evening to discuss the third quarter results
DermCare Management, a premier provider of dermatology and cosmetic surgery practice management services in Florida, Texas, California, and Virginia, is excited to announce the expansion of its family with a new partnership in California, increasing its total number of locations to 81. https://mma.prnewswire.com/media/1736237/DermCare_Logo.jpg “We are excited to add Dr. Jochen and the entire team at